Robert J. Lee

Robert J. Lee's work focuses on developing nanoparticle and lipid-based delivery systems for drugs and nucleic acids (like antisense oligonucleotides and small RNAs) to treat conditions such as cancer, osteoarthritis, and neurodegenerative diseases. Much of the research is applied pharmaceutical science, combining formulation techniques (such as solid lipid nanoparticles and solid dispersions) with testing in cell and animal models to improve how therapeutics are delivered and absorbed in the body. The publication record includes both full research articles and conference abstracts, often in collaboration with industry or clinical research groups.

Publication output has declined over the past decade, dropping from around 25 papers per year in 2017-2019 to roughly 8 per year on average over the last five years, with a notable dip in 2024 before a slight rebound in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026